156 related articles for article (PubMed ID: 6774362)
1. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1980; 69(3):227-33. PubMed ID: 6774362
[TBL] [Abstract][Full Text] [Related]
2. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.
Murugaiah K; Theodorou A; Jenner P; Marsden CD
Neuroscience; 1983 Nov; 10(3):811-9. PubMed ID: 6685826
[TBL] [Abstract][Full Text] [Related]
4. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):135-44. PubMed ID: 6103813
[TBL] [Abstract][Full Text] [Related]
5. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
[TBL] [Abstract][Full Text] [Related]
6. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
Hong M; Kilpatrick GJ; Jenner P; Marsden CD
Neuropharmacology; 1987 Aug; 26(8):1061-9. PubMed ID: 2889161
[TBL] [Abstract][Full Text] [Related]
8. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1985; 86(1-2):228-32. PubMed ID: 3927361
[TBL] [Abstract][Full Text] [Related]
9. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Clow A; Jenner P; Theodorou A; Marsden CD
Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
[No Abstract] [Full Text] [Related]
11. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
12. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
[No Abstract] [Full Text] [Related]
13. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
16. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
17. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
Clow A; Theodorou A; Jenner P; Marsden CD
Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
[No Abstract] [Full Text] [Related]
18. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
19. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
Cameron DL; Crocker AD
Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
[TBL] [Abstract][Full Text] [Related]
20. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
